Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Additional provision for US RMBS investigations

26 Jan 2017 07:00

RNS Number : 1779V
Royal Bank of Scotland Group PLC
26 January 2017
 

The Royal Bank of Scotland Group plc

Additional provision for US RMBS investigations and litigation

 

26 January 2017

 

 

The Royal Bank of Scotland Group plc (together with its subsidiaries, "RBS") will announce its Full Year 2016 results on 24 February 2017. Subject to any increase being required by intervening developments, the Q4 2016 results will reflect the taking of a further £3.1bn ($3.8bn) provision in relation to various investigations and litigation matters relating to RBS's issuance and underwriting of US residential mortgage-backed securities ("RMBS"). This takes the total aggregate of such provisions to £6.7bn ($8.3bn) as at 31 December 2016. This further provision would have reduced RBS's Tangible Net Asset Value ("TNAV") per share at 30 September 2016 by 27p to 311p and RBS's Q3 2016 CET1 capital ratio by 135bps to 13.6%. This provision does not directly impact the distributable reserves of The Royal Bank of Scotland Group plc.

 

RBS continues to cooperate with the US Department of Justice ("DOJ") in its civil and criminal investigations of RMBS matters, and RBS considers it appropriate to take this provision now in relation to those investigations as well as other RMBS litigation matters. The duration and outcome of these investigations and other RMBS litigation matters remain uncertain, including in respect of whether settlements for all or any of such matters may be reached.

 

RBS emphasises that further substantial additional provisions and costs may be recognised and, depending on the final outcome, other adverse consequences may occur (see RBS's existing market disclosures). The existing disclosures also provide further details of the US RMBS-related investigations by the DOJ and other agencies and bodies, including several state attorneys general, and various litigation matters.

 

Ross McEwan, RBS's Chief Executive Officer, said:

 

"Putting our legacy litigation issues behind us, including those relating to RMBS, remains a key part of our strategy. It is our priority to seek the best outcome for our shareholders, customers and employees."

 

Ross McEwan (Chief Executive Officer) and Ewen Stevenson (Chief Financial Officer) will host a conference call for investors and analysts at 8.00am UK time today. A replay of the call will be made available shortly afterwards. Only items relating to the above announcement will be discussed on the call; there will be no references and discussion relating to other matters and the Full Year 2016 results. Dial-in details for the call can be found below.

 

Dial-in details:

UK: 0800 694 8082

International: +44 (0) 1452 568 172

US: +1 866 966 8024

Conference ID: 60246489

 

Replay details:

UK FreeCall: 0800 953 1533

Std International: +44 (0)1452 550 000

USA FreeCall: +1 (866) 247 4222

Conference ID: 60246489

 

 

For further information, please contact:

 

Investor Relations

Alexander Holcroft

Head of Equity Investor Relations

+44 (0) 20 7672 1758

 

Matthew Richardson

Head of Fixed Income Investor Relations

+44 (0) 20 7678 1800

 

RBS Media Relations

+44 (0) 131 523 4205

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK Annual Report and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQQLBLDFFZBBX
Date   Source Headline
28th Apr 201510:58 amRNSRBS Announces Management Change at Williams & Glyn
27th Apr 20157:00 amRNSFurther Sale of North American Loan Portfolio
23rd Apr 20155:22 pmRNSDividend Declaration
22nd Apr 201512:21 pmRNSCitizens 1Q 2015 Results
15th Apr 20155:56 pmRNSAllotment and Issue of New Ordinary Shares
13th Apr 201511:30 amRNSBlock Listing Return
2nd Apr 20155:59 pmRNSPublication of Registration Document
2nd Apr 20155:57 pmRNSPublication of Prospectus
2nd Apr 20154:56 pmRNSForm TR-1
1st Apr 20159:00 amRNSFILING OF ANNUAL REPORT ON FORM 20-F
31st Mar 20156:27 pmRNSAnnual Report and Accounts 2014
31st Mar 20155:18 pmRNSTotal Voting Rights
30th Mar 20151:07 pmRNSManagement Changes
27th Mar 20157:30 amRNSDisposal of Private Banking and Wealth Businesses
26th Mar 20157:03 amRNSDirector Declaration
26th Mar 20157:01 amRNSPartial Sale of Citizens Financial Group, Inc.
24th Mar 20159:45 amRNSMorgan Stanley European Financials Conference
23rd Mar 201511:03 amRNSIntention to Sell Part of Citizens Financial Group
18th Mar 20157:30 amRNSDe-listing of Ordinary Shares from Euronext
9th Mar 20154:13 pmRNSDirector/PDMR Shareholding
6th Mar 20151:02 pmRNSDirector/PDMR Shareholding
6th Mar 20151:00 pmRNSRemuneration Disclosures
27th Feb 20154:56 pmRNSTotal Voting Rights
26th Feb 20154:27 pmRNSTR1A
26th Feb 20157:05 amRNSSale of North American loan portfolio
26th Feb 20157:02 amRNSDirectorate Change
26th Feb 20157:02 amRNSFinal Results - Part 2
26th Feb 20157:01 amRNSFinal Results - Part 1
19th Feb 20155:45 pmRNSDividend Declaration
19th Feb 20153:00 pmRNSAdditional Listing
3rd Feb 20155:56 pmRNSRBS notes credit ratings downgrade by S&P
30th Jan 20154:05 pmRNSTotal Voting Rights
29th Jan 201510:29 amRNSForm 8.3 - [WYG plc]
26th Jan 201512:12 pmRNSCitizens Full Year 2014 Results
21st Jan 20153:41 pmRNSNotices of Redemption
15th Jan 201512:28 pmRNSHolding(s) in Company
8th Jan 201512:20 pmRNSNotice of Redemption
8th Jan 201512:13 pmRNSNotice of Redemption
31st Dec 201412:07 pmRNSTotal Voting Rights
23rd Dec 20141:20 pmRNSNotices of Redemption
23rd Dec 201411:40 amRNSPublication of Prospectus
18th Dec 20143:00 pmRNSNotice of Redemption
16th Dec 20147:30 amRNSSale of a Portfolio of Irish Real Estate Loans
16th Dec 20147:05 amRNS2014 Bank of England Stress Test Results
15th Dec 20144:45 pmRNSHolding(s) in Company
9th Dec 20145:00 pmRNSDirector/PDMR Shareholding
5th Dec 20142:00 pmRNSDirector/PDMR Shareholding
28th Nov 20143:42 pmRNSTotal Voting Rights
27th Nov 20143:15 pmRNSPublication of Supplementary Prospectus
25th Nov 20145:52 pmRNSAllotment and Issue of New Ordinary Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.